Increased Levels of Soluble Fas Ligand in Serum in Plasmodium falciparum Malaria
AUTOR(ES)
Kern, Peter
FONTE
American Society for Microbiology
RESUMO
Levels of soluble Fas ligand (sFasL) in serum were elevated in patients with Plasmodium falciparum malaria and showed a significant decline during disease course. sFasL levels that were elevated before antimalarial treatment began correlated significantly with depressed total lymphocyte and T-cell counts. These data suggest that Fas-induced apoptosis might play a role in malaria-associated lymphopenia.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=97531Documentos Relacionados
- Increased Levels of Soluble CD30 in Plasma of Patients with Plasmodium falciparum Malaria
- Levels of stem cell factor and interleukin-3 in serum in acute Plasmodium falciparum malaria.
- Evolution of the levels of soluble interleukin-2 receptors during Plasmodium falciparum and P. vivax malaria.
- Levels of cytokines in plasma during Plasmodium falciparum malaria attacks.
- Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.
